ZDHHC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.520800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.629800E-01
Normal-vs-Stage2
3.862000E-01
Normal-vs-Stage3
5.676000E-01
Normal-vs-Stage4
1.468640E-01
Stage1-vs-Stage2
4.836400E-01
Stage1-vs-Stage3
1.124800E-01
Stage1-vs-Stage4
8.669400E-01
Stage2-vs-Stage3
7.158500E-02
Stage2-vs-Stage4
4.297600E-01
Stage3-vs-Stage4
9.346200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.552800E-01
Normal-vs-AfricanAmerican
2.842800E-01
Normal-vs-Asian
6.034800E-01
Caucasian-vs-AfricanAmerican
8.002400E-01
Caucasian-vs-Asian
4.567200E-01
AfricanAmerican-vs-Asian
4.814200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.083000E-01
Normal-vs-Female
3.105200E-01
Male-vs-Female
1.877360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.197200E-01
Normal-vs-Age(41-60Yrs)
1.974580E-01
Normal-vs-Age(61-80Yrs)
4.975200E-01
Normal-vs-Age(81-100Yrs)
2.904400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.061800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.569450E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.239000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.477900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.064000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.733600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.732000E-01
Normal-vs-Daily Drinker
3.313600E-01
Normal-vs-Weekly Drinker
5.876400E-01
Normal-vs-Occasional Drinker
1.610150E-01
Normal-vs-Social Drinker
2.849600E-01
Non Drinker-vs-Daily Drinker
2.688400E-01
Non Drinker-vs-Weekly Drinker
8.930000E-01
Non Drinker-vs-Occasional Drinker
1.318410E-02
Non Drinker-vs-Social Drinker
1.152360E-01
Daily Drinker-vs-Weekly Drinker
2.979600E-01
Daily Drinker-vs-Occasional Drinker
1.608420E-01
Daily Drinker-vs-Social Drinker
5.525800E-01
Weekly Drinker-vs-Occasional Drinker
3.629900E-02
Weekly Drinker-vs-Social Drinker
1.608350E-01
Occasional Drinker-vs-Social Drinker
5.068600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.023600E-01
Normal-vs-Grade 2
6.375000E-01
Normal-vs-Grade 3
1.257430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.197200E-01
Grade 1-vs-Grade 3
4.875400E-01
Grade 1-vs-Grade 4
3.023600E-01
Grade 2-vs-Grade 3
1.115700E-02
Grade 2-vs-Grade 4
6.375000E-01
Grade 3-vs-Grade 4
1.257430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.596400E-01
Normal-vs-NonDiabetic
2.780000E-01
Diabetic-vs-NonDiabetic
1.093630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.766500E-02
Normal-vs-NoPancreatitis
3.853200E-01
Pancreatitis-vs-NoPancreatitis
1.894450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.618600E-01
Normal-vs-N1
3.662600E-01
N0-vs-N1
9.679800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.808200E-02
Normal-vs-TP53-NonMutant
3.639200E-01
TP53-Mutant-vs-TP53-NonMutant
1.427190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
